TrialHaematologica2016

Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma.

Katja C Weisel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.